Search company, investor...

Predict your next investment

Private Equity
hbhtgroup.com

Investments

6

Funds

1

About Hongtai Capital

The firm operates state-owned capital and makes equity investments in China.

Headquarters Location

137 Xudong Avenue Hubei Energy Building, 12th-14th Floor

Wuhan, Hubei, 430077,

China

86 27 87137096

Want to inform investors similar to Hongtai Capital about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Hongtai Capital News

CGene Tech of Suzhou Raises $14.5 Million in Series A+ Round to Develop Small-Molecule Drugs

Aug 2, 2019

publication date: Aug 2, 2019 CGene Tech, a Suzhou BioBay novel small molecule drug developer, raised $14.5 million in a Series A+ financing, led by Hongtai Capital with ABC International participating. CGene's lead candidate is an innovative cetagliptin phosphate DPP-4 inhibitor for type 2 diabetes that has completed a Phase I trial in China. CGene said it would use the proceeds from the round to advance the clinical program for its hypoglycemic drug and support development of its oncology candidates and generic drugs for rare diseases. More details.... Share this with colleagues: Sorry this page is available to subscribers only. If you're not a subscriber why not subscribe today? If you are already a subscriber, please login. If you believe you should have received this message in error, please contact us .

Hongtai Capital Investments

6 Investments

Hongtai Capital has made 6 investments. Their latest investment was in Taihe Petrochemical as part of their Series C on January 1, 2023.

CBI Logo

Hongtai Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

1/18/2023

Series C

Taihe Petrochemical

Yes

6/20/2022

Series A

Subscribe to see more

Subscribe to see more

0

2/22/2022

Series D

Subscribe to see more

Subscribe to see more

0

5/21/2021

Seed

Subscribe to see more

Subscribe to see more

0

1/19/2021

Series C

Subscribe to see more

Subscribe to see more

0

Date

1/18/2023

6/20/2022

2/22/2022

5/21/2021

1/19/2021

Round

Series C

Series A

Series D

Seed

Series C

Company

Taihe Petrochemical

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

0

0

0

0

Hongtai Capital Acquisitions

1 Acquisition

Hongtai Capital acquired 1 company. Their latest acquisition was CICC Tongsheng on April 12, 2023.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

4/12/2023

$99M

Corporate Majority

1

Date

4/12/2023

Investment Stage

Companies

Valuation

$99M

Total Funding

Note

Corporate Majority

Sources

1

Hongtai Capital Fund History

1 Fund History

Hongtai Capital has 1 fund, including Xianning Jianyang Equity Investment Co. Ltd..

Closing Date

Fund

Fund Type

Status

Amount

Sources

Xianning Jianyang Equity Investment Co. Ltd.

Multi-Stage Venture Capital

Open

1

Closing Date

Fund

Xianning Jianyang Equity Investment Co. Ltd.

Fund Type

Multi-Stage Venture Capital

Status

Open

Amount

Sources

1

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.